Trihexyphenidyl
DrugBank ID: DB00376
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| attention deficit-hyperactivity disorder | 0.9992 | DL |
| juvenile onset Parkinson disease 19A | 0.9990 | DL |
| faciodigitogenital syndrome | 0.9986 | DL |
| atypical juvenile parkinsonism | 0.9982 | DL |
| hereditary late onset Parkinson disease | 0.9982 | DL |
| X-linked parkinsonism-spasticity syndrome | 0.9976 | DL |
| attention deficit hyperactivity disorder, inattentive type | 0.9975 | DL |
| Rasmussen subacute encephalitis | 0.9966 | DL |
| PLA2G6-associated neurodegeneration | 0.9958 | DL |
| congenital disorder of glycosylation with defective fucosylation | 0.9956 | DL |
| polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis | 0.9956 | DL |
| hemiparkinsonism-hemiatrophy syndrome | 0.9955 | DL |
| retinal dystrophy with or without extraocular anomalies | 0.9954 | DL |
| myelitis | 0.9954 | DL |
| Charcot-Marie-Tooth disease, demyelinating, type 1G | 0.9954 | DL |
| parkinsonian-pyramidal syndrome | 0.9952 | DL |
| atypical glycine encephalopathy | 0.9947 | DL |
| blepharospasm | 0.9946 | DL |
| Parkinson disease | 0.9945 | DL |
| early-onset parkinsonism-intellectual disability syndrome | 0.9945 | DL |
| myopia 26, X-linked, female-limited | 0.9945 | DL |
| specific developmental disorder | 0.9945 | DL |
| myopia X-linked | 0.9945 | DL |
| transaldolase deficiency | 0.9931 | DL |
| syndromic myopia | 0.9931 | DL |
| schizophrenia | 0.9928 | DL |
| fructose-1,6-bisphosphatase deficiency | 0.9926 | DL |
| progressive supranuclear palsy-corticobasal syndrome | 0.9924 | DL |
| hydranencephaly (disease) | 0.9920 | DL |
| paralysis agitans, juvenile, of Hunt | 0.9919 | DL |
| Lewy body dementia | 0.9919 | DL |
| X-linked intellectual disability-ataxia-apraxia syndrome | 0.9911 | DL |
| X-linked intellectual disability-cerebellar hypoplasia syndrome | 0.9908 | DL |
| chondromyxoid fibroma | 0.9907 | DL |
| CLCN4-related X-linked intellectual disability syndrome | 0.9897 | DL |
| X-linked intellectual disability-spastic quadriparesis syndrome | 0.9895 | DL |
| syndromic X-linked intellectual disability Chudley-Schwartz type | 0.9887 | DL |
| X-linked intellectual disability with hypopituitarism | 0.9887 | DL |
| X-linked cerebral-cerebellar-coloboma syndrome syndrome | 0.9886 | DL |
| X-linked spasticity-intellectual disability-epilepsy syndrome | 0.9886 | DL |
| hydrocephaly-cerebellar agenesis syndrome | 0.9886 | DL |
| intellectual disability, X-linked, syndromic | 0.9886 | DL |
| Paganini-Miozzo syndrome | 0.9885 | DL |
| Prieto syndrome | 0.9884 | DL |
| X-linked intellectual disability-hypotonia-movement disorder syndrome | 0.9884 | DL |
| X-linked intellectual disability, Stocco dos Santos type | 0.9884 | DL |
| parkinsonian disorder | 0.9883 | DL |
| lethal infantile mitochondrial myopathy | 0.9883 | DL |
| intellectual developmental disorder, X-linked, syndromic, Hackmann-Di Donato type | 0.9881 | DL |
| NAA10-related syndrome | 0.9879 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.